Trials / Sponsors / Acumen Pharmaceuticals
Acumen Pharmaceuticals
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC Alzheimer Disease | Phase 1 | 2024-06-25 |
| Active Not Recruiting | A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disea Alzheimer Disease | Phase 2 | 2024-02-29 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD Alzheimer Disease | Phase 1 | 2021-06-21 |